D. Rossner

Neuroprotection with amifostine in the first-line treatment of advanced ovarian cancer with carboplatin/paclitaxel-based chemotherapy—a double-blind, placebo-controlled, randomized phase II study from the Arbeitsgemeinschaft Gynäkologische Onkologoie (AGO) Ovarian Cancer Study Group

A. Burges, F. Hilpert, A. Bois, 2005, Supportive Care in Cancer.

Combined NT-pro-BNP and CW-Doppler ultrasound cardiac output monitoring (USCOM) in epirubicin and liposomal doxorubicin therapy.

K. Knobloch, K. Busch, P. Vogt, 2008, International journal of cardiology.

An Open-Label, Multicenter Study of Outpatient Capecitabine Monotherapy in 631 Patients with Pretreated Advanced Breast Cancer

R. Paridaens, M. Salzberg, J. Nortier, 2007, Oncology.

[Rhabdomyolysis after administration of diclofenac].

K. Knobloch, M. Richter, C. Krettek, 2005, Der Unfallchirurg.

[Prevention of school sport injuries--an analysis of ballsports with 2234 injuries].

K. Knobloch, M. Richter, C. Krettek, 2005, Sportverletzung Sportschaden : Organ der Gesellschaft fur Orthopadisch-Traumatologische Sportmedizin.

Traumatic tricuspid insufficiency after horse kick.

K. Knobloch, Stefan Fischer, R. Leyh, 2004, The Journal of trauma.

Non-invasive cardiac output determination by two-dimensional independent Doppler during and after cardiac surgery.

Artur Lichtenberg, Karsten Knobloch, Michael Winterhalter, 2005, The Annals of thoracic surgery.

NEUROPROTECTION WITH AMIFOSTINE IN THE 1ST-LINE TREATMENT OF ADVANCED OVARIAN CANCER WITH CARBOPLATIN/TAXANE-BASED CHEMOTHERAPY – A DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED PHASE II-STUDY FROM THE AGO OVARIAN CANCER STUDY GROUP

A. du Bois, A. Stahle, A. Burges, 2004, International Journal of Gynecologic Cancer.